Cellular and Molecular Imaging with SPECT and PET in Brain Tumors

被引:7
作者
Sadaghiani, Mohammad S. [1 ]
Sheikhbahaei, Sara [1 ]
Rowe, Steven P. [1 ]
Pomper, Martin G. [1 ]
Solnes, Lilja B. [1 ]
机构
[1] Johns Hopkins Univ, Russell H Morgan Dept Radiol & Radiol Sci, Sch Med, 601 North Caroline St,JHOC 3150, Baltimore, MD 21287 USA
关键词
Brain tumor; PET; SPECT; Molecular imaging; MEMBRANE ANTIGEN PSMA; HIGH-GRADE GLIOMA; F-18-FDG PET; FDG-PET; O-(2-F-18-FLUOROETHYL)-L-TYROSINE PET; C-11-ACETATE PET/CT; CLINICAL-USE; HYPOXIA; DIFFERENTIATION; C-11-METHIONINE;
D O I
10.1016/j.rcl.2021.01.005
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Brain neoplasms include a diverse group of primary tumors as well as secondary tumors or metastases from neoplasms outside the central nervous system (CNS), which occur more frequently than the primary brain tumors. The incidence rate of primary CNS tumors in adults in the United States is approximately 30 per 100,000 population, with approximately one-third of these tumors being malignant.1 Single-photon emission computed tomography Brain neoplasms include a diverse group of primary tumors as well as secondary tumors or metastases from neoplasms outside the central nervous system (CNS), which occur more frequently than the primary brain tumors. The incidence rate of primary CNS tumors in adults in the United States is approximately 30 per 100,000 population, with approximately one-third of these tumors being malignant.1 Single-photon emission computed tomography
引用
收藏
页码:363 / 375
页数:13
相关论文
共 50 条
[21]   Biomedical imaging: SPECT and PET [J].
Lecomte, Roger .
NUCLEAR PHYSICS METHODS AND ACCELERATORS IN BIOLOGY AND MEDICINE, 2007, 958 :115-122
[22]   Molecular imaging using PET and SPECT for identification of breast cancer subtypes [J].
Liu, Hao ;
Chen, Yao ;
Wu, Shuang ;
Song, Fahuan ;
Zhang, Hong ;
Tian, Mei .
NUCLEAR MEDICINE COMMUNICATIONS, 2016, 37 (11) :1116-1124
[23]   SPECT and PET radiopharmaceuticals for molecular imaging of apoptosis: from bench to clinic [J].
Wang, Xiaobo ;
Feng, Han ;
Zhao, Shichao ;
Xu, Junling ;
Wu, Xinyu ;
Cui, Jing ;
Zhang, Ying ;
Qin, Yuhua ;
Liu, Zhiguo ;
Gao, Tang ;
Gao, Yongju ;
Zeng, Wenbin .
ONCOTARGET, 2017, 8 (12) :20476-20495
[24]   Clinical application of 201Tl SPECT imaging of brain tumors [J].
Sun, D ;
Liu, QC ;
Liu, WG ;
Hu, WW .
JOURNAL OF NUCLEAR MEDICINE, 2000, 41 (01) :5-10
[25]   Brain SPECT as a Biomarker of Neurodegeneration in Dementia in the Era of Molecular Imaging: Still a Valid Option? [J].
Ferrando, Rodolfo ;
Damian, Andres .
FRONTIERS IN NEUROLOGY, 2021, 12
[26]   Recent Developments in PET and SPECT Radiotracers as Radiopharmaceuticals for Hypoxia Tumors [J].
Nguyen, Anh Thu ;
Kim, Hee-Kwon .
PHARMACEUTICS, 2023, 15 (07)
[27]   Is there a preference for PET or SPECT brain imaging in diagnosing dementia? The views of people with dementia, carers, and healthy controls [J].
Bamford, Claire ;
Olsen, Kirsty ;
Davison, Chris ;
Barnett, Nicky ;
Lloyd, Jim ;
Williams, David ;
Firbank, Michael ;
Mason, Helen ;
Donaldson, Cam ;
O'Brien, John .
INTERNATIONAL PSYCHOGERIATRICS, 2016, 28 (01) :123-131
[28]   PET and SPECT imaging of the brain: a review on the current status of nuclear medicine in Japan [J].
Tomohiro Kaneta .
Japanese Journal of Radiology, 2020, 38 :343-357
[29]   Immuno-Imaging (PET/SPECT)-Quo Vadis? [J].
Kramer, Carsten S. ;
Dimitrakopoulou-Strauss, Antonia .
MOLECULES, 2022, 27 (10)
[30]   PET and SPECT imaging of the brain: a review on the current status of nuclear medicine in Japan [J].
Kaneta, Tomohiro .
JAPANESE JOURNAL OF RADIOLOGY, 2020, 38 (04) :343-357